Detalhe da pesquisa
1.
Safety and Efficacy of Insulins in Critically Ill Patients Receiving Continuous Enteral Nutrition.
Endocr Pract
; 30(4): 367-371, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38307456
2.
Cardiovascular Safety of Antidiabetic Drugs in the Hospital Setting.
Curr Diab Rep
; 17(8): 64, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28699089
3.
Insulin Resistance in a Hospitalized COVID-19 Patient: A Case Review.
Clin Diabetes
; 39(2): 228-232, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33986579
4.
Effect of glargine insulin delivery method (pen device versus vial/syringe) on glycemic control and patient preferences in patients with type 1 and type 2 diabetes.
Endocr Pract
; 20(6): 536-9, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24326004
5.
Transitional care clinic for uninsured and medicaid-covered patients with diabetes mellitus discharged from the hospital: a pilot quality improvement study.
Hosp Pract (1995)
; 42(1): 46-51, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24566596
6.
Hitting the target for inpatient glycemic management.
Nurse Pract
; 36(5): 24-31; quiz 31-2, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21487318
7.
Comparison of 70/30 biphasic insulin with glargine/lispro regimen in non-critically ill diabetic patients on continuous enteral nutrition therapy.
Nutr Clin Pract
; 26(6): 714-7, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22205560
8.
Pilot study of using neutral protamine Hagedorn insulin to counteract the effect of methylprednisolone in hospitalized patients with diabetes.
J Hosp Med
; 6(3): 175-6, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21387555